We expressed the gag and proteinase regions of human immunodeficiency virus (HIV) type 1 by transcription and translation in vitro. A synthetic RNA spanning the gag and pro domains gave primarily the unprocessed capsid precursor pr53. Efficient cleavage of this precursor was observed when the gag and pro domains were placed in the same translational reading frame, yielding equimolar amounts of the gag protein and of proteinase (PR). Expression of HIV type 1 PR in Escherichia coli as a fusion protein gave rapid autocatalytic processing to an HIV-specific protein of approximately 11 kilodaltons. HIV PR generated in E. coli specifically induced cleavage of the HIV capsid precursor, whereas deletion of the carboxy-terminal 17 amino acids of the proteinase rendered it inactive. Inhibitor studies showed that the enzyme was insensitive to inhibitors of serine and cysteine proteinases and metalloproteinases and was inhibited only by a very high concentration (1 mM) of pepstatin A.
The genomes of all replication-competent retroviruses, including human immunodeficiency virus (HIV), consist of three major genetic elements that are arranged in the order 5'-gag-pol-env-3'. The structural proteins of the nucleocapsid (encoded by the gag gene) and the viral replication enzymes (encoded by the pol gene) are exclusively synthesized as polyproteins that are proteolytically processed to the mature viral proteins by a virus-encoded proteinase (for reviews, see references 12 and 27) . The products of the pol gene are generated only by translation of a large gag-pol polyprotein, and synthesis of this polyprotein is achieved by translational frameshifting in the 3'-terminal part of the gag gene (8) . The viral proteinases (PRs [13] ) from a number of avian (3, 26) and mammalian (28) (29) (30) retroviruses have been purified and characterized. These enzymes share limited sequence homology with the aspartic proteinases, especially in the region surrounding the proposed catalytic center (9, 19, 23) , but are much smaller than the aspartic proteinases and contain only a single homologous aspartic acid residue. The proteolytic enzyme of HIV type 1 has been studied by expression of various parts of the pol reading frame in yeast cells (10) , baculovirus (14) , and Escherichia coli expression vectors (2, 4, 5, 16) . The proteolytic activity maps to an 11-kilodalton (kDa) protein (99 amino acids) that is encoded immediately upstream of the viral reverse transcriptase and that appears to be generated by autocatalytic release from a larger precursor protein (2) .
We report here the construction of an expression plasmid (pHIVproPII) that places the region from nucleotides (nt) 1640 to 2129 of the HIV cDNA under the control of the promoter and untranslated region of bacteriophage T7 gene 10. This vector was constructed by digestion of plasmid pBHX10 (20) with EcoRI and KpnI, followed by digestion with Dral. The 788-base-pair fragmrent ( (22) . In parallel experiments we transformed E. coli BL21(DE3) with the vector plasmid pAR2106 (containing no HIV sequences) and with plasmid pHIVproP, which is similar to pHIVproPII but has a deletion of the 17 3'-terminal codons of the proteinase gene. This plasmid was constructed by ligating the BglII-HincII fragment (nt 1640 to 2078 of HIV cDNA) with the BamHI-EcoRI (filled) fragment of pAR2106.
The products from these expression plasmids after induction and labeling with [35S]methionine are shown in Fig. 1A . Bacteria carrying the vector plasmid (pAR2106) primarily produced P-lactamase, which is encoded on the plasmid in the same orientation as the T7 promoter. Induction of bacteria harboring pHIVproP and pHIVproPII gave additional products of approximately 17 and 11 kDa, respectively. Immunoblot analysis of the bacterial lysates with a polyclonal antiserum against HIV PR (1) specifically detected the 17-kDa protein in the pHIVproP lane and the protein in the pHIVproPII lane (Fig. 1B) . No (Fig. 2A) .
This mutagenesis changed the nucleotide sequence from AAG ATC TGG to AAG ATC GAT C TG G and therefore leads to an insertion of an Asp codon (GAT) and to a s'witch from the gag reading frame (TGG = Trp) to the pol reading frame (CTG = Leu). This switch occurs only four codons after the start of the pol reading frame, and the primary translation product therefore closely resembles the product generated in vivo by translational frameshifting. 4396 NOTES system, since rapid and efficient cleavage occurs. It is possible that cleavage depends on a certain minimal concentration of enzyme, especially if the enzyme needs to form a dimer, as has been proposed (18) , and that this "minimal cleavage concentration" is only achieved in vivo once the enzyme reaches a certain (virus-induced?) compartment. This hypothesis could be supported by our observation that equimolar expression of substrate and enzyme gives efficient cleavage.
In further experiments we used the translation product from g/p(H) RNA as a substrate for HIV PR generated in E. coli. RRLs, programmed with g/p(H) RNA, were either analyzed directly after translation (Fig. 2B, lane 7 (Fig. 2B, lane 6 ). The only difference was a protein migrating slightly more slowly than the p24 capsid protein (designated p24 in Fig. 2B ). This protein was also observed in a previous study (10) (Fig. 2C, lane 1) while an S10 supernatant from bacterial lysates after expression of the pHIVproPII vector was used to provide the enzyme (Fig. 2C, lanes 2 to 8) . In a preliminary experiment we determined that most of the HIV-specific proteolytic activity was contained in an S10 supernatant (data not shown). Bacteria carrying pHIVproPII were lysed into 20 mM Tris hydrochloride-0.1 M NaCl (pH 7.5) without a reducing agent, an S10 fraction was prepared, and dithiothreitol (DTT) was added to 2.5 mM except when indicated. The S10 fraction (enzyme) was then diluted 1:10 into lysis buffer (with or without DTT). This was done because the enzyme concentration used in the previous experiment gave complete cleavage and minor inhibitory effects might therefore be missed. Accordingly, incubation of the RRL translation products (substrate; Fig. 2C , lane 1) with a bacterial S10 fraction (diluted 1:10) gave incomplete cleavage of the precursor protein, and the expected products were observed (Fig. 2C, lane 2) . The efficiency and pattern of cleavage were identical regardless of whether DTT was present (Fig. 2C, lane 2 (6) . It has been proposed that the HIV PR forms a dimer (9, 18) , and dimerization might be facilitated by hydrophobic interaction, particularly since the enzyme has a very high number of hydrophobic residues. Performing the cleavage reaction in a final concentration of 1% Triton X-100 (Fig. 2C, lane 8) tration of inhibitor had no effect on the pattern or efficiency of the processing in RRLs. The concentration of pepstatin A required to give some inhibition of activity was several orders of magnitude higher than the concentration required for inhibition by pepsin or even renin (24) . This requirement for very high pepstatin concentrations agrees with results previously reported for the proteinases of bovine and murine leukemia viruses and human T-cell lymphotropic virus type I. In all these instances the 50% inhibitory concentration of pepstatin A was approximately 0.5 mM (9) . It has previously been shown that pepstatin A does not inhibit serine and cysteinle proteinases, even at a concentration of >0.36 mM (24) . Inhibition of the HIV proteinase with pepstatin A therefore probably reflects a true similarity of the catalytic mechanism with that of aspartic proteinases.
